William B. Armstrong

Chair, Department of Otolaryngology-HNS, Otolaryngology
School of Medicine

M.D., University of Washington (Seattle)

Phone: (714) 456-5750
Fax: (714) 456-5747
Email: wbarmstr@uci.edu

University of California, Irvine
Building 56, Suite 500
101 The City Drive
Mail Code: 5386
Orange, CA 92868

picture of William B. Armstrong

Research
Interests
Head & Neck Oncology, early detection of H & N cancer, H & N cancer prevention
   
URL Department website
   
Publications Armstrong WB, Vokes D. Malignant Tumors of the Larynx. 5th Edition of Cummings Otolaryngology Head & Neck Surgery, March 2010, Vol 2, Chapter 107, 1482-511
   
  Rubinstein, M., Fine, E., Sepehr, A., Armstrong, W. B., Crumley, R., Kim, J., Chen, Z., Wong, B. (2010). Optical Coherence Tomography of the Larynx Using the Niris System. Journal of Otolaryngology-Head & Neck Surgery, 39(2), 150-6.
   
  Kaiser, M. L., Rubinstein, M., Vokes, D. E., Ridgway, J. M., Guo, S., Gu, M., Crumley, R. L., Armstrong, W. B., Chen, Z., Wong, B. (2009). Laryngeal Epithelial Thickness: A Comparison Between Optical Coherence Tomography and Histology. Clinical Otolaryngology, 34, 460-466.
   
  Sepehr A, Gutierrez Santos BJ, Chou C, Karimi K, Devcic Z, Oels S, Armstrong B, Antibiotics in Head and Neck Surgery: Malnutrition, Tracheotomy, and Diabetes The Laryngoscope 2009; Mar 119:549-553
   
  Armstrong WB, Ridgway JM, Vokes DE, Guo S, Perez J, Jackson RP, Gu M, Su J, Crumley RL, Shibuya TY, Mahmood U, Chen Z, Wong, BJF Optical Coherence Tomography of Laryngeal Cancer , Laryngoscope 2006;116:1107-13.
   
  Armstrong WB, Wan XS, Kennedy AR, Taylor TH, Ph.D., Frank L. Meyskens FL Jr. Development of the Bowman-Birk Inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor Concentrate treatment. Laryngoscope 2003;113(10):1687-702.
   
  Armstrong WB, Taylor TH, Meyskens FL Jr. Point: Surrogate end point biomarkers are likely to be limited in their usefulness in the development of cancer chemoprevention agents against sporadic cancers. Cancer Epidemiology, Biomarkers and prevention, 2003; 12(7):589-92.
   
  Armstrong WB, Kennedy AR, Wan XS, Taylor TH, Jensen J, Thompson W, Lagerberg W, Meyskens FL. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate a phase IIa chemoprevention trial. Clinical Cancer Research.2000;6:4684-91.
   
Professional
Societies
American Academy of Otolaryngology-Head and Neck Surgery
American College of Surgeons
   
   
Link to this profile http://www.faculty.uci.edu/profile.cfm?faculty_id=2914
   
Last updated 01/23/2012